TITLE

Regaining control: a critique of drug legalisation policies

AUTHOR(S)
Steel, Alan
PUB. DATE
March 2006
SOURCE
Drugs & Alcohol Today;Mar2006, Vol. 6 Issue 1, p19
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article explores the potential benefits of licensing drug sales to stop drug use and cut the increasing power of the black market. A free market of legalisation would still not exist, even if drug production, sale and use were brought into a legal framework. Ways to control legal drug sales are presented which could primarily be undertaken by the pharmaceutical industry.
ACCESSION #
20484014

 

Related Articles

  • The Criminal Mind. Auerbach, Michael // Pharmaceutical Processing;Aug2010, Vol. 25 Issue 8, p6 

    The author reflects on the issue of counterfeiting in relation to pharmaceutical industry. He argues that product counterfeiting is designed to fool the unaware consumer or just the gullible into the thought that they are getting genuine merchandise for a fraction of its original cost. The...

  • Robust Market Testing CROs' Ability to Deliver. Miller, Jim // BioPharm International;Sep2007, Vol. 20 Issue 9, p26 

    The article talks about the capacity of several service providers in handling current market growth. They admit that their systems and management are inadequate. The capacity problems reflect an unprecedented level of activity in the development services industry. This growth is expected to come...

  • BLACK MEDICINE. Shepherd, Marv // Americas Quarterly;Summer2010, Vol. 4 Issue 3, p82 

    The article discusses the prevalence of drug counterfeiting in the world and its impact on health care services. According to a survey conducted by the Center for Medicines in the Public Interest, the incidence of global counterfeit drug trade will reach 75 billion in 2010. It mentions that Asia...

  • Initial Impact of the Legalization of Cannabis on Criminality in Uruguay. Weinberger, David // International Journal on Criminology;Winter2018/Spring2019, Vol. 6 Issue 2, p33 

    South America is not besieged by cannabis, and that the legalization of the drug could only ever have a limited direct impact on criminality. The negative aspects of the legislation, must certainly not overshadow its positive impacts, in particular the central role given to the state in the form...

  • Pharmaceutical product ID: An industry in crisis? Levin, Aaron // Drug Topics;9/3/2001, Vol. 145 Issue 17, p42 

    Focuses on the influence of the quantity of drug dispensed on reimbursements or rebates in the United States. Problems of pharmacists in dispensing drugs; Complains on the use of nonstandard packaging by manufacturers; Goals of the National Council for Prescription Drug Programs.

  • A prescription for better prescriptions. Woosley, Raymond L. // Issues in Science & Technology;Spring94, Vol. 10 Issue 3, p59 

    Discusses the dependency of physicians on drug companies as the primary source of information about pharmaceuticals. High cost of marketing; Bias scientific literature; Prescribing practices of physicians; Establishment of federally funded centers for education and research in therapeutics...

  • Using market models to forecast demand for ethical pharmaceuticals. Latta, Michael // Journal of Business Forecasting Methods & Systems;Spring98, Vol. 17 Issue 1, p3 

    Discusses the use of market models to forecast demand for ethical pharmaceutical products. Scenarios to consider in forecasts; Creation of a base case using the patient market model; Need for management approval for assumptions used in the model.

  • Rx.  // Drug Topics;6/7/99, Vol. 143 Issue 11, p55 

    Offers information on several prescription drugs in the United States. Indications of Ovide; Reason for the labeling change of Isuprel; Information on some generic drugs.

  • Distant drumming. Koberstein, Wayne // Pharmaceutical Executive;Nov98, Vol. 18 Issue 11, p12 

    Discusses issues regarding direct-to-consumer (DTC)-promoted products in the pharmaceutical industry. Concerns on DTC marketing; Highlights of the WorldPharm conference held September 1, 1998.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics